NO872675L - Middel for hemning av avstoetning av transplanterte organer - Google Patents

Middel for hemning av avstoetning av transplanterte organer

Info

Publication number
NO872675L
NO872675L NO872675A NO872675A NO872675L NO 872675 L NO872675 L NO 872675L NO 872675 A NO872675 A NO 872675A NO 872675 A NO872675 A NO 872675A NO 872675 L NO872675 L NO 872675L
Authority
NO
Norway
Prior art keywords
heparin
disposal
inhibiting
humans
transplanted organs
Prior art date
Application number
NO872675A
Other languages
English (en)
Norwegian (no)
Other versions
NO872675D0 (no
Inventor
Irun Cohen
Israel Vlodavsky
Amiram Eldor
Yaakov Naparstek
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO872675D0 publication Critical patent/NO872675D0/no
Publication of NO872675L publication Critical patent/NO872675L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Paper (AREA)
  • Fertilizers (AREA)
  • Soil Working Implements (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO872675A 1986-06-26 1987-06-25 Middel for hemning av avstoetning av transplanterte organer NO872675L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL79254A IL79254A0 (en) 1986-06-26 1986-06-26 Compositions for preventing graft rejection

Publications (2)

Publication Number Publication Date
NO872675D0 NO872675D0 (no) 1987-06-25
NO872675L true NO872675L (no) 1987-12-28

Family

ID=11056896

Family Applications (1)

Application Number Title Priority Date Filing Date
NO872675A NO872675L (no) 1986-06-26 1987-06-25 Middel for hemning av avstoetning av transplanterte organer

Country Status (10)

Country Link
EP (1) EP0251134B1 (de)
JP (1) JP2527749B2 (de)
AT (1) ATE82502T1 (de)
AU (1) AU608228B2 (de)
DE (1) DE3782686T2 (de)
DK (1) DK169422B1 (de)
ES (1) ES2052514T3 (de)
GR (1) GR3006814T3 (de)
IL (1) IL79254A0 (de)
NO (1) NO872675L (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85145A (en) * 1987-01-23 1994-08-26 Univ Australian Anti-metastatic pharmacological or veterinary preparations containing modified herpin with reduced anticoagulant activity
US5541166A (en) * 1987-01-23 1996-07-30 The Australian National University Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity
GB8808810D0 (en) * 1988-04-14 1988-05-18 Biopharm Clinical Research Ltd Heparin-containing formulations
IL86753A0 (en) * 1988-06-15 1988-11-30 Hadassah Med Org Pharmaceutical compositions for treatment of lupus
DE3821271A1 (de) * 1988-06-23 1989-12-28 Solco Basel Ag Derivatisiertes heparin, verfahren zu dessen herstellung und arzneimittel, welches dieses enthaelt
IL88554A0 (en) * 1988-12-01 1989-07-31 Hadassah Med Org Compositions containing a compound binding to a heparin receptor
US5158940A (en) * 1990-02-14 1992-10-27 The United States Government As Represented By The Secretary, Dhhs Use of suramin to treat rheumatologic diseases
EP0998941B9 (de) 1997-07-14 2007-03-14 Takashi Muramatsu Verwendung von midkin oder von anti-midkin antikörper
US20050137167A1 (en) 2001-09-12 2005-06-23 Benito Casu Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
US6538028B1 (en) 2000-02-01 2003-03-25 Vanderbilt University Method for inhibiting complement activation
CN1197587C (zh) * 2000-06-09 2005-04-20 中国科学院上海细胞生物学研究所 N-位脱硫酸肝素在预防和治疗炎症中的应用
EP2165711B1 (de) 2004-05-27 2014-05-21 Baxter International Inc. Verfahren zur Behandlung von Blutungsstörungen mittels sulfatierter Polysaccharide
JP5896742B2 (ja) 2008-08-22 2016-03-30 バクスター・ヘルスケヤー・ソシエテ・アノニムBaxter Healthcare SA 出血性障害を処置するための方法
WO2011088267A1 (en) 2010-01-14 2011-07-21 Baxter International Inc. Methods and compositions for treating bleeding disorders
EP2734213B1 (de) 2011-07-19 2018-06-06 Baxalta GmbH Resorptionsförderer als additive zur verbesserung der oralen formulierung nicht-antikoagulierender sulfatierter polysaccharide
CA2881785A1 (en) 2012-08-14 2014-02-20 Baxter International Inc. Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides
EP2968400B1 (de) 2013-03-12 2019-05-08 Baxalta GmbH Resorptionsförderer als additive zur verbesserung der oralen formulierung von niedermolekularen heparinen
SE538503C2 (en) 2014-11-11 2016-08-16 Tx Medic Ab New dextran sulfate
WO2016198578A1 (en) * 2015-06-11 2016-12-15 Universiteit Maastricht Method for preventing transplant failure in a host.
AU2023203192B2 (en) * 2022-05-06 2024-03-14 Bargent Therapeutics Pty Limited Methods of treating allograft rejection

Also Published As

Publication number Publication date
DE3782686T2 (de) 1993-06-09
EP0251134A3 (en) 1989-05-03
AU608228B2 (en) 1991-03-28
IL79254A0 (en) 1986-09-30
DK331287D0 (da) 1987-06-26
EP0251134B1 (de) 1992-11-19
NO872675D0 (no) 1987-06-25
ES2052514T3 (es) 1994-07-16
DK169422B1 (da) 1994-10-31
EP0251134A2 (de) 1988-01-07
JPS6388127A (ja) 1988-04-19
AU7470687A (en) 1988-01-07
DE3782686D1 (de) 1992-12-24
ATE82502T1 (de) 1992-12-15
GR3006814T3 (de) 1993-06-30
JP2527749B2 (ja) 1996-08-28
DK331287A (da) 1987-12-27

Similar Documents

Publication Publication Date Title
NO872675D0 (no) Middel for hemning av avstoetning av transplanterte organer
ZA858676B (en) Method and system for removing immunosppressive components from the blood of mammals
ES2137225T3 (es) Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
AU5841090A (en) Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same
DE69033487D1 (de) Behandlung von autoimmunkrankheiten durch verabreichung von autoantigenen in form von aerosol
ATE10340T1 (de) Stabilisierung der aktivitaet des faktors viii im blutplasma.
MX9101869A (es) Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
ES2082850T3 (es) Inmunoglobulinas preparadas geneticamente.
DK602387D0 (da) Fremgangsmaade til fremstilling af glucosaminer med lav molekylvaegt og anvendelse af saadanne glucosaminer
DE69435303D1 (de) Er behandlung von krankheiten bei denen eine cytok
NZ210275A (en) Modified hirudin and its antithrombin properties
DE69132048D1 (de) Verwendung von Steroiden zur Inhibierung von Angiogenesis
ES2147780T3 (es) Compuestos sinteticos afines al extracto de corteza de roble, y procedimiento para utilizar los mismos.
WO1979000853A1 (fr) Produit medicinal pour organe circulatoire
DE3584560D1 (de) Arzneimittelzusammensetzung geeignet zur behandlung oder prophylaxe von herzstoerungen.
ATE215967T1 (de) Aus harn isolierte antikoagulierende verbindung
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
EP0058397A3 (de) Antikoagulans und seine Verwendung
ES2032192T3 (es) Composiciones elastomeras reticulables.
NO832092L (no) Fremgangsmaate ved fremstilling av et heparinfragment
ATE113591T1 (de) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol- - one und ihre verwendung als antikonvulsiva.
SE7905810L (sv) Spiroketaliner och deras anvendningar
ATE90558T1 (de) Antivirale zusammensetzungen mit aromatischen polycyclischen dionen sowie methode zur behandlung retroviraler infektionen.
BR8400127A (pt) Composicao para o combate de crescimento indesejado de plantas,processo para a obtencao de 3,4-di-(metilamino)-6-terc.-butil-4,5-dihidro-1,2,4-triazin-5-ona,processo para a obtencao de uma composicao utilizacao e processo para o combate de ervas daninhas